CTC immune escape mediated by PD-L1

被引:37
|
作者
Wang, Xuefei
Sun, Qiang
Liu, Qiaofei
Wang, Changjun
Yao, Ru
Wang, Yimin
机构
[1] Chinese Acad Med Sci, Breast Surg Dept, Beijing, Peoples R China
[2] Peking Union Med Coll, Peking Union Med Coll & Hosp, Beijing, Peoples R China
[3] Shanxi Prov Peoples Hosp, Xian, Shaanxi, Peoples R China
关键词
BREAST-CANCER; CELLS; SUPPRESSION;
D O I
10.1016/j.mehy.2016.05.022
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Breast cancer is the most common malignant tumor in women around the world. Most breast cancer related deaths are from CTC (circulating tumor cells) metastasis. CTC is associated with the breast cancer patients' prognosis. But recently, circulating clusters were found and its metastasis and tumor formation ability is 23-50 times as CTC. However, its mechanism has not been clarified. These days, researchers have successfully completed CTC cluster separation, CTC cell culture, and PD-L1 was found to be related with histological grading of tumor. Meanwhile, the high expression of PD-L1 in CTC surface has also been reported. Since PD-L1 can mediate Treg to play the role of immunosuppression, we propose that CTC with positive PD-L1 is easier to connect PD-L1, immune cells (Treg regulatory T cells, MDSC bone marrow inhibitory cells) and CM cytokines etc. On one hand, Treg cells can protect CTC from being attacked by the immune system through the immunosuppression, on the other hand, they can weaken CTL killing ability and trigger more MDSC. Finally, CTC formed the metastatic lesion. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:138 / 139
页数:2
相关论文
共 50 条
  • [31] UBTF facilitates acute myeloid leukemia development and immune escape via PD-L1 regulation
    Yang, Chunxia
    Wan, Junzhao
    Wang, Yan
    Yang, Ying
    Ran, Yunsheng
    Zhang, Fenli
    Zhou, Man
    Liu, Ping
    Kang, Qian
    Ma, Dan
    Yang, Xiaoyan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 152
  • [32] Inhibition of c-MET upregulates PD-L1 related immune escape in lung adenocarcinoma
    Sun, Xian
    Li, Chia-Wei
    Wang, Wei-Jan
    Hung, Mien-Chie
    CANCER RESEARCH, 2020, 80 (16)
  • [33] LDHB Mediates Histone Lactylation to Activate PD-L1 and Promote Ovarian Cancer Immune Escape
    Hu, Xuemei
    Huang, Zhenqiang
    Li, Lingyun
    CANCER INVESTIGATION, 2025, 43 (01) : 70 - 79
  • [34] USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression
    Li, Bing
    Wang, Bin
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (07) : 1921 - 1937
  • [35] A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor
    Leroy, L.
    Lafarge, X.
    Blouin, L.
    Bijou, F.
    Durrieu, F.
    Olivier, E.
    Le Moulec, S.
    ANNALS OF ONCOLOGY, 2018, 29 (02) : 514 - 515
  • [36] Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
    Ricklefs, Franz L.
    Alayo, Quazim
    Krenzlin, Harald
    Mahmoud, Ahmad B.
    Speranza, Maria C.
    Nakashima, Hiroshi
    Hayes, Josie L.
    Lee, Kyungheon
    Balaj, Leonora
    Passaro, Carmela
    Rooj, Arun K.
    Krasemann, Susanne
    Carter, Bob S.
    Chen, Clark C.
    Steed, Tyler
    Treiber, Jeffrey
    Rodig, Scott
    Yang, Katherine
    Nakano, Ichiro
    Lee, Hakho
    Weissleder, Ralph
    Breakefield, Xandra O.
    Godlewski, Jakub
    Westphal, Manfred
    Lamszus, Katrin
    Freeman, Gordon J.
    Bronisz, Agnieszka
    Lawler, Sean E.
    Chiocca, E. Antonio
    SCIENCE ADVANCES, 2018, 4 (03):
  • [37] PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression
    Tang, Haidong
    Liang, Yong
    Anders, Robert A.
    Taube, Janis M.
    Qiu, Xiangyan
    Mulgaonkar, Aditi
    Liu, Xin
    Harrington, Susan M.
    Guo, Jingya
    Xin, Yangchun
    Xiong, Yahong
    Nham, Kien
    Silvers, William
    Hao, Guiyang
    Sun, Xiankai
    Chen, Mingyi
    Hannan, Raquibul
    Qiao, Jian
    Dong, Haidong
    Peng, Hua
    Fu, Yang-Xin
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (02): : 580 - 588
  • [38] CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
    Chen, Limo
    Diao, Lixia
    Yang, Yongbin
    Yi, Xiaohui
    Rodriguez, Leticia
    Li, Yanli
    Villalobos, Pamela A.
    Cascone, Tina
    Liu, Xi
    Tan, Lin
    Lorenzi, Philip L.
    Huang, Anfei
    Zhao, Qiang
    Peng, Di
    Fradette, Jared J.
    Peng, David H.
    Ungewiss, Christin
    Roybal, Jonathon
    Tong, Pan
    Oba, Junna
    Skoulidis, Ferdinandos
    Peng, Weiyi
    Carter, Brett W.
    Gay, Carl M.
    Fan, Youhong
    Class, Caleb A.
    Zhu, Jingfen
    Rodriguez-Canales, Jaime
    Kawakami, Masanori
    Byers, Lauren Averett
    Woodman, Scott E.
    Papadimitrakopoulou, Vassiliki A.
    Dmitrovsky, Ethan
    Wang, Jing
    Ullrich, Stephen E.
    Wistuba, Ignacio I.
    Heymach, John V.
    Qin, F. Xiao-Feng
    Gibbons, Don L.
    CANCER DISCOVERY, 2018, 8 (09) : 1156 - 1175
  • [39] Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors
    Knopf, Philipp
    Stowbur, Dimitri
    Hoffmann, Sabrina H. L.
    Hermann, Natalie
    Maurer, Andreas
    Bucher, Valentina
    Poxleitner, Marilena
    Tako, Bredi
    Sonanini, Dominik
    Krishnamachary, Balaji
    Sinharay, Sanhita
    Fehrenbacher, Birgit
    Gonzalez-Menendez, Irene
    Reckmann, Felix
    Bomze, David
    Flatz, Lukas
    Kramer, Daniela
    Schaller, Martin
    Forchhammer, Stephan
    Bhujwalla, Zaver M.
    Quintanilla-Martinez, Leticia
    Schulze-Osthoff, Klaus
    Pagel, Mark D.
    Fransen, Marieke F.
    Roecken, Martin
    Martins, Andre F.
    Pichler, Bernd J.
    Ghoreschi, Kamran
    Kneilling, Manfred
    MOLECULAR CANCER, 2023, 22 (01)
  • [40] Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624-mediated PD-L1 pathway
    Jin, Guilin
    Ma, Mi
    Yang, Chunyan
    Zhen, Luo
    Feng, Mingke
    THORACIC CANCER, 2023, 14 (24) : 2493 - 2503